Tracking Semaglutide: Dose Titration and Side Effects

Semaglutide is unusual in the peptide world because it has gone fully mainstream as a prescription medication. Whether someone is using it under medical supervision or as a self-experimenter, the tracking problem is the same: dose changes slowly over months, side effects shift with each step, and outcomes are easy to misattribute.

This guide focuses on the injectable weekly form (Ozempic / Wegovy). As of January 2026 there is now also an oral semaglutide 25 mg tablet approved for chronic weight management (branded oral Wegovy), which follows the OASIS trial data and comes with strict fasting-administration rules. If you are tracking the pill rather than the pen, see the dedicated oral semaglutide guide - the titration logic here still applies, but the daily dosing ritual and absorption caveats differ.

The titration shape

Most semaglutide protocols follow a stepped titration:

• Week 1–4: starter dose
• Week 5–8: step 2
• Week 9–12: step 3
• Week 13+: target dose

The exact mg per step varies. The structure is consistent: change one variable, hold for a few weeks, evaluate, then change again.

What to track daily

A short daily log captures the most signal:

• Appetite score (1–10) — how easy is it to skip a meal?
• Nausea score (0–10)
• Energy (1–10)
• GI symptoms — bloating, constipation, reflux
• Hydration — total fluid intake in ml or cups

You do not need lab-grade precision. You need consistency. Same scale, every day.

What to track weekly

• Weight — same scale, same time, same clothing
• Waist circumference — one of the better proxies for body composition change
• Body photos — front, side, back; same lighting

Daily weigh-ins are noisy. Weekly weigh-ins are a trend.

What to track at each dose increase

This is where most logs fall apart. People remember to log doses and forget to log step changes.

At every titration step:

• The new dose
• Date of first administration
• Side effects for the first 7 days after the step
• Any required dose hold (some people hold an extra week before stepping up)

Peptid AI treats a titration as a multi-step protocol so the steps appear on the same timeline as your doses.

Side effects worth logging in detail

• Nausea — often peaks 1–3 days after a dose increase
• GI motility changes — constipation is more common than diarrhea
• Heartburn / reflux — slowed gastric emptying is the mechanism
• Injection site reactions — redness, itching
• Mood changes — appetite-suppressing effects sometimes correlate

If a side effect lasts beyond ~2 weeks at a given step, that is a signal to discuss holding or reducing the dose with your physician.

Outcome metrics

Beyond weight, the questions worth answering:

• Energy at fixed caloric intake — are you tired or fine?
• Workout performance — strength, endurance, recovery
• Bloodwork — see the separate post on bloodwork during cycles

The "is this working" question

Semaglutide effects compound over months, not days. If you weigh yourself daily and panic about a 0.5 kg bump, you are reading noise. Log weekly. Look at 4-week rolling averages. Only judge effectiveness on at least 8 weeks of data.

Holds and pauses

Tracking gets confusing during pauses (travel, side-effect holds, supply gaps). Mark these explicitly. A 2-week pause looks like a plateau if you do not annotate it. Peptid AI treats a hold as a first-class event so the timeline stays honest.

Coming off

Most users see appetite return over weeks after stopping. Continue logging during the taper and for at least 8 weeks after the final dose — that is where the long-term picture lives.

Peptid AI is an educational and self-tracking tool. Nothing in this post is medical advice. Doses mentioned reflect what is commonly reported in research literature — they are not recommendations. Always consult a qualified physician before starting, changing, or stopping any protocol.